STENOCARE DK-08
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
STENOCARE DK-08 (S7C) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, STENOCARE DK-08 (S7C) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
STENOCARE DK-08 - Net Assets Trend (None–None)
This chart illustrates how STENOCARE DK-08's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for STENOCARE DK-08 (None–None)
The table below shows the annual net assets of STENOCARE DK-08 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to STENOCARE DK-08's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
STENOCARE DK-08 Competitors by Market Cap
The table below lists competitors of STENOCARE DK-08 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Petrolympic Ltd
PINK:PCQRF
|
$3.88 Million |
|
Yunnan Water Investment Co. Limited
F:2WI
|
$3.88 Million |
|
Golden Arrow Resources Corp
OTCQB:GARWF
|
$3.88 Million |
|
TX Rail Products, Inc
PINK:TXRP
|
$3.88 Million |
|
KOAS Co. Ltd
KO:071950
|
$3.88 Million |
|
National Stock Yards Co
PINK:NSYC
|
$3.88 Million |
|
Silo Pharma Inc
OTCQB:SILO
|
$3.88 Million |
|
ADM Endeavors Inc
OTCQB:ADMQ
|
$3.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STENOCARE DK-08's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares STENOCARE DK-08's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently STENOCARE DK-08 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares STENOCARE DK-08's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STENOCARE DK-08 (S7C) | €- | N/A | N/A | $3.88 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |